1997
DOI: 10.1136/gut.40.1.123
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic treatment of early oesophageal or gastric cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
90
0
7

Year Published

1998
1998
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 176 publications
(100 citation statements)
references
References 10 publications
1
90
0
7
Order By: Relevance
“…In our department, since 1992, we have employed EMR in which we use, a cap-fitted panendoscope (EMRC) [1][2][3][4].…”
Section: Introductionmentioning
confidence: 99%
“…In our department, since 1992, we have employed EMR in which we use, a cap-fitted panendoscope (EMRC) [1][2][3][4].…”
Section: Introductionmentioning
confidence: 99%
“…Dr. Furukawa, of the Osaka Medical Center for Cancer and Cardiovascular Disease, introduced a report from the Osaka cancer population-based registry showing a declining trend in reported gastric cancer mortality, but indicating that the morbidity of gastric cancer is still the highest among other cancers [9]. Nevertheless, in recent years, since the development of EMR, surgical resections for early gastric cancer are declining [3]. It should be noted that EMR patients will be included in the results for treatment of gastric cancer in future statistics.…”
Section: Total Number Of Gastric Cancer Patients Treated Surgicallymentioning
confidence: 99%
“…The proportion of patients with early gastric cancer has increased steadily, from approximately 20% in the 1970s to 50% in the 1990s [1]. Endoscopic mucosal resection (EMR) and limited surgery are commonly employed for patients with early gastric cancer [3], while, D2 or more extensive lymph node dissection has commonly been employed safely the treatment results at each institution, the 5-year survival rates, determined by the Kaplan-Meier method, were employed.…”
Section: Introductionmentioning
confidence: 99%
“…In Western countries, some studies reporting results aft er ER for AC of the esophagus suggested a favorable prognosis, although the rates of local and metachronous recurrence were relatively high (4.2 ~ 21.5 % ) ( 15,16 ). Similarly, in Japan, some studies suggested a favorable prognosis aft er ER for SCC of the esophagus (0 ~ 2.3 % ) ( 17,18 ), although the rates of local and metachronous recurrence were also relatively high (16.4 ~ 20 % ) ( 19,20 ). In addition, it had been reported that the rate of lymph node metastasis was low in both SCC ( 21 ) and AC ( 22 -26 ) when the lesion was limited to the superfi cial submucosa (SM1).…”
Section: Introductionmentioning
confidence: 99%